摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-7-甲基-1,5-二氢-4H-咪唑并[4,5-d]哒嗪-4-酮 | 813462-81-6

中文名称
2-溴-7-甲基-1,5-二氢-4H-咪唑并[4,5-d]哒嗪-4-酮
中文别名
——
英文名称
2-bromo-7-methyl-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one
英文别名
2-Bromo-7-methyl-1H-imidazo[4,5-d]pyridazin-4(5H)-one;2-bromo-4-methyl-1,6-dihydroimidazo[4,5-d]pyridazin-7-one
2-溴-7-甲基-1,5-二氢-4H-咪唑并[4,5-d]哒嗪-4-酮化学式
CAS
813462-81-6
化学式
C6H5BrN4O
mdl
——
分子量
229.036
InChiKey
PKSJIJDQHKYRAW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    70.1
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:593056de8b8a2a78d88ce7552916a1a0
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-7-甲基-1,5-二氢-4H-咪唑并[4,5-d]哒嗪-4-酮 、 alkaline earth salt of/the/ methylsulfuric acid 在 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以83%的产率得到2-bromo-3-(2-butyn-1-yl)-7-methyl-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one
    参考文献:
    名称:
    Synthesis of 2-bromo-7-methyl-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one and 3-alkyl-2-bromo-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one and their selective elaboration
    摘要:
    Two synthetic routes to the versatile 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones 2 and 5 have been developed that allow the production of multigram quantities without the need of any chromatographic purification. Broad and selective elaboration of the heteroaromatic scaffolds has also been accomplished. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2008.01.102
  • 作为产物:
    描述:
    7-methylimidazo<4,5-d>pyridazin-4-onepotassium carbonate 作用下, 以 乙腈 为溶剂, 以61%的产率得到2-溴-7-甲基-1,5-二氢-4H-咪唑并[4,5-d]哒嗪-4-酮
    参考文献:
    名称:
    [DE] IMIDAZOPYRIDAZINON- UND IMIDAZOPYRIDONDERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL
    [EN] IMIDAZO-PYRIDAZINONE DERIVATIVES AND IMIDAZO-PYRIDONE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS
    [FR] DERIVES D'IMIDAZOPYRIDAZINONES ET D'IMIDAZOPYRIDONES, LEUR PREPARATION ET LEUR UTILISATION COMME MEDICAMENTS
    摘要:
    This invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula (I), where Y and R1 to R4 are as defined in claim 1, their tautomers, enantiomers, diastereomers, mixtures thereof, and their salts, which possess valuable pharmacological properties, particularly inhibitory effects on the activity of the enzyme dipeptidyl peptidase-IV (DPP-IV).
    公开号:
    WO2004111051A1
点击查看最新优质反应信息

文献信息

  • New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
    申请人:Eckhardt Matthias
    公开号:US20050026921A1
    公开(公告)日:2005-02-03
    The present invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula wherein Y and R 1 to R 4 are defined as in claim 1, the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及通式所示的取代咪唑吡啶酮和咪唑吡啶酮,其中Y和R1至R4如权利要求1中所定义,其互变异构体、对映体、非对映体、它们的混合物及其盐,具有有价值的药理特性,特别是对二肽基肽酶-IV(DPP-IV)酶活性的抑制作用。
  • IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    申请人:ECKHARDT Matthias
    公开号:US20090258856A1
    公开(公告)日:2009-10-15
    The present invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula wherein Y and R 1 to R 4 are defined as in claim 1 , the tautomers, enantiomers, diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及通式如下的取代咪唑吡啶酮和咪唑吡嗪酮: 其中Y和R1至R4的定义如权利要求1所述,它们的互变异构体、对映异构体、顺反异构体、其混合物和盐具有有价值的药理学性质,特别是对二肽基肽酶-IV(DPP-IV)酶活性的抑制作用。
  • IMIDAZOPYRIDAZINON- UND IMIDAZOPYRIDONDERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP1641799B1
    公开(公告)日:2008-03-12
  • US7566707B2
    申请人:——
    公开号:US7566707B2
    公开(公告)日:2009-07-28
  • US8034941B2
    申请人:——
    公开号:US8034941B2
    公开(公告)日:2011-10-11
查看更多